Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.

Merchan JR, Ferrell A, Macintyre J, Ciombor KK, Levi J, Ribeiro A, Sleeman D, Flores A, Lopes G, Rocha-Lima CM
Am J Clin Oncol. 2012 35 (5): 446-50

PMID: 21552097 · DOI:10.1097/COC.0b013e31821862fb

MeSH Terms (21)

Adenocarcinoma Adult Aged Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Carcinoma, Pancreatic Ductal Carcinoma, Squamous Cell Cetuximab Deoxycytidine Female Follow-Up Studies Humans Male Middle Aged Neoplasm Staging Organoplatinum Compounds Oxaliplatin Pancreatic Neoplasms Survival Rate Treatment Outcome

Connections (2)

This publication is referenced by other Labnodes entities: